Tawakaltu Omolara Tijani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tawakaltu Omolara Tijani has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Olaiya Akeem Ayodele
Department of Pharmaceutical Chemistry, Ahmadu Bello University, Zaria, Nigeria
5 shared publications - Dauda Garba
Department of Pharmaceutical and Medicinal Chemistry, University of Abuja, Abuja, Nigeria
4 shared publications - Mohammed Ibrahim Sule
Department of Pharmaceutical and Medicinal Chemistry, Ahmadu Bello University, Zaria 810107, Nigeria
4 shared publications - Akande Amatul-Hafeez
Department of Pharmaceutical Chemistry, Ahmadu Bello University, Zaria, Nigeria
2 shared publications - Atiku Ibrahim
Department of Pharmaceutical Chemistry and Medicinal Chemistry, Ahmadu Bello University, Zaria, 810107 Nigeria
2 shared publications - Yusuf Jimoh
Department of Pharmaceutical and Medicinal Chemistry, Ahmadu Bello University, Zaria 810107, Nigeria
2 shared publications
Latest Publications
- Open Access
- 2 July 2025
- Published by Etflin in Sciences of Phytochemistry
- Vol. 4 (2) , 85-90
Exploring the Anti-Malarial Potential of Terminalia brownii Fresen: A Phytochemical and Biological Activity Study
Terminalia brownii is a widely distributed African tree traditionally used to treat ailments such as cough, malaria, hepatitis, and microbial infections. The growing resistance of Plasmodium falciparum to Artemisinin combination therapy and other antimalarial drugs highlights the need for new therapies with improved potency and fewer side effects. This study analyzed the phytochemical constituents and antiplasmodial activity of T. brownii leaf extracts. The leaves were air-dried, powdered, and macerated in 70% methanol, followed by fractionation with n-hexane, chloroform, and ethyl acetate. Qualitative analysis of the methanol crude extract (MCE) revealed tannins, flavonoids, alkaloids, triterpenes, steroids, saponins, phenols, and cardiac glycosides, but not anthraquinones. Quantitative analysis showed phenols (195.45 mg/g), tannins (156.10 mg/g), and flavonoids (135.10 mg/g) as the most abundant. The ethyl acetate fraction contained phenols (103 mg/g) and tannins (69.56 mg/g) but lacked steroids and triterpenes. Antiplasmodial activity was evaluated in Plasmodium berghei-infected mice. The LD50 of the crude extract exceeded 5000 mg/kg, and significant dose-dependent suppression of parasitemia (p<0.05) was observed at 250, 500, and 1000 mg/kg. These findings support the traditional use of T. brownii against malaria and encourage further studies on its bioactive fractions and compounds.
- 2 July 2025
- Published by Etflin in Sciences of Phytochemistry
- Vol. 4 (2) , 85-90
Open AccessExploring the Anti-Malarial Potential of Terminalia brownii Fresen: A Phytochemical and Biological Activity Study
Terminalia brownii is a widely distributed African tree traditionally used to treat ailments such as cough, malaria, hepatitis, and microbial infections. The growing resistance of Plasmodium falciparum to Artemisinin combination therapy and other antimalarial drugs highlights the need for new therapies with improved potency and fewer side effects. This study analyzed the phytochemical constituents and antiplasmodial activity of T. brownii leaf extracts. The leaves were air-dried, powdered, and macerated in 70% methanol, followed by fractionation with n-hexane, chloroform, and ethyl acetate. Qualitative analysis of the methanol crude extract (MCE) revealed tannins, flavonoids, alkaloids, triterpenes, steroids, saponins, phenols, and cardiac glycosides, but not anthraquinones. Quantitative analysis showed phenols (195.45 mg/g), tannins (156.10 mg/g), and flavonoids (135.10 mg/g) as the most abundant. The ethyl acetate fraction contained phenols (103 mg/g) and tannins (69.56 mg/g) but lacked steroids and triterpenes. Antiplasmodial activity was evaluated in Plasmodium berghei-infected mice. The LD50 of the crude extract exceeded 5000 mg/kg, and significant dose-dependent suppression of parasitemia (p<0.05) was observed at 250, 500, and 1000 mg/kg. These findings support the traditional use of T. brownii against malaria and encourage further studies on its bioactive fractions and compounds.
- Open Access
- 24 May 2025
- Published by Science Publishing Group in Journal of Drug Design and Medicinal Chemistry
- Vol. 11 (2) , 31-38
Computational Insights into the Antimalarial Potential of Geranylated Chalcone from Terminalia brownii : A Multi-target Approach Against Plasmodium Falciparum Enzymes
The emergence of resistance to existing antimalarial therapies has escalated the urgency for novel compounds that effectively inhibit Plasmodium falciparum . This comprehensive study explores the antimalarial potential of Geranylated Chalcone, a bioactive compound extracted from Terminalia brownii . The molecular structure of Geranylated Chalcone was generated and optimized using ChemDraw and Spartan14 software, respectively, and evaluated its theoretical bioavailability and toxicity profiles through the SwissADME web platform and ProTox 3.0 tool. Molecular docking studies was performed with AutoDock Vina to assess binding interactions with critical enzymes, including Falcipain-2, Falcipain-3, Plasmepsin-2, and Aminopeptidase. Geranylated Chalcone displayed notable binding affinities ranging from -6.4 to -7.3 kcal/mol, indicating substantial interactions facilitated by hydrogen bonds, van der Waals forces, and pi interactions. Furthermore, the compound demonstrated a favorable drug-likeness profile, adhering to Lipinski's rule of five and exhibiting low toxicity (LD 50 : 2652mg/kg). These findings substantiate that Geranylated Chalcone serves as a promising candidate for antimalarial drug development, possessing advantageous binding affinities and a multi-target profile. Elucidation of its therapeutic efficacy, in vitro and in vivo studies are essential to validate its potentiality as a groundbreaking antimalarial agent. This research contributes valuable insights into the multifaceted role of natural compounds in combating malaria and the pressing challenge of drug resistance.
- 24 May 2025
- Published by Science Publishing Group in Journal of Drug Design and Medicinal Chemistry
- Vol. 11 (2) , 31-38
Open AccessComputational Insights into the Antimalarial Potential of Geranylated Chalcone from Terminalia brownii : A Multi-target Approach Against Plasmodium Falciparum Enzymes
The emergence of resistance to existing antimalarial therapies has escalated the urgency for novel compounds that effectively inhibit Plasmodium falciparum . This comprehensive study explores the antimalarial potential of Geranylated Chalcone, a bioactive compound extracted from Terminalia brownii . The molecular structure of Geranylated Chalcone was generated and optimized using ChemDraw and Spartan14 software, respectively, and evaluated its theoretical bioavailability and toxicity profiles through the SwissADME web platform and ProTox 3.0 tool. Molecular docking studies was performed with AutoDock Vina to assess binding interactions with critical enzymes, including Falcipain-2, Falcipain-3, Plasmepsin-2, and Aminopeptidase. Geranylated Chalcone displayed notable binding affinities ranging from -6.4 to -7.3 kcal/mol, indicating substantial interactions facilitated by hydrogen bonds, van der Waals forces, and pi interactions. Furthermore, the compound demonstrated a favorable drug-likeness profile, adhering to Lipinski's rule of five and exhibiting low toxicity (LD 50 : 2652mg/kg). These findings substantiate that Geranylated Chalcone serves as a promising candidate for antimalarial drug development, possessing advantageous binding affinities and a multi-target profile. Elucidation of its therapeutic efficacy, in vitro and in vivo studies are essential to validate its potentiality as a groundbreaking antimalarial agent. This research contributes valuable insights into the multifaceted role of natural compounds in combating malaria and the pressing challenge of drug resistance.
- Open Access
- 21 January 2025
- Published by Science Publishing Group in Journal of Drug Design and Medicinal Chemistry
- Vol. 11 (1) , 8-12
Isolation and Characterization of Geranylated Chalcone from Ethylacetate Fraction of Terminalia brownii Fresen (Combretaceae)
Terminalia brownii is a deciduous tree characterized by spirally arranged leaves concentrated at the ends of its branches. The plant is widely distributed in Northern Nigeria and other part of Africa, including Congo, Kenya, Sudan, Ethiopia, and Tanzania. Traditionally, it is used for treating various conditions such as gastric ulcers, epilepsy, colitis, jaundice, fungal infections, diarrhea, malaria, hepatitis, and allergic reactions. This study aimed to analyzed the crude methanol leave extract and ethyl acetate fraction of Terminalia brownii to isolate secondary metabolites. Plant material was collected, air-dried, pulverized, and extracted using cold maceration with 70% methanol. The resulting crude methanol extract was fractionated with n-hexane, chloroform, ethyl acetate, and n-butanol to yield their respective fractions. The ethyl acetate underwent extensive column chromatography using silica gel and Sephadex LH-20. Structural characterization of the isolated compound was conducted through physical and chemical analysis, UV and IR spectroscopy, advanced 1D and 2D NMR techniques, supported by literature references. This process resulted in the isolation of a yellow amorphous compound, identified as 2’,6’,4-trihydroxy-3’-methoxy-4-O-prenyloxy chalcone (geranylated chalcone). The compound is isolated for the first time from Terminalia brownii leave, this discovery convey Terminalia brownii as a rich source of secondary metabolites and contributes to the taxonomy of the plant.
- 21 January 2025
- Published by Science Publishing Group in Journal of Drug Design and Medicinal Chemistry
- Vol. 11 (1) , 8-12
Open AccessIsolation and Characterization of Geranylated Chalcone from Ethylacetate Fraction of Terminalia brownii Fresen (Combretaceae)
Terminalia brownii is a deciduous tree characterized by spirally arranged leaves concentrated at the ends of its branches. The plant is widely distributed in Northern Nigeria and other part of Africa, including Congo, Kenya, Sudan, Ethiopia, and Tanzania. Traditionally, it is used for treating various conditions such as gastric ulcers, epilepsy, colitis, jaundice, fungal infections, diarrhea, malaria, hepatitis, and allergic reactions. This study aimed to analyzed the crude methanol leave extract and ethyl acetate fraction of Terminalia brownii to isolate secondary metabolites. Plant material was collected, air-dried, pulverized, and extracted using cold maceration with 70% methanol. The resulting crude methanol extract was fractionated with n-hexane, chloroform, ethyl acetate, and n-butanol to yield their respective fractions. The ethyl acetate underwent extensive column chromatography using silica gel and Sephadex LH-20. Structural characterization of the isolated compound was conducted through physical and chemical analysis, UV and IR spectroscopy, advanced 1D and 2D NMR techniques, supported by literature references. This process resulted in the isolation of a yellow amorphous compound, identified as 2’,6’,4-trihydroxy-3’-methoxy-4-O-prenyloxy chalcone (geranylated chalcone). The compound is isolated for the first time from Terminalia brownii leave, this discovery convey Terminalia brownii as a rich source of secondary metabolites and contributes to the taxonomy of the plant.
- Open Access
- 9 January 2025
- Published by Etflin in Sciences of Phytochemistry
- Vol. 4 (1) , 55-61
Phytochemical and Antiplasmodial Studies of Methanol Extract from Aerial Parts of Scadoxus multiflorus
Scadoxus multiflorus, a fleshy herbaceous plant with a large bulb, has been traditionally used in ethnomedicine for treatment of malaria, ulcers, cardiotonic activity and stimulant in debility. This study aimed to conduct phytochemical screening and evaluate the antiplasmodial activity of its aerial parts. The plant material was extracted with methanol using maceration process, and the crude extract was partitioned into hexane, chloroform, ethyl acetate, and butanol fractions. Qualitative phytochemical screening revealed the presence of tannins, flavonoids, alkaloids, terpenoids, steroids, saponins, phenols, and cardiac glycosides in the crude extract and fractions. Quantitative analysis revealed that phenolic compounds were the most abundant in the crude extract (198.32 mg/g), while alkaloids were the least (51.14 mg/g). The n-hexane fraction, however, had the highest tannin content (215 mg/g). Acute toxicity testing, following OECD 2008 guidelines, showed that the median lethal dose (LD₅₀) was greater than 5000 mg/kg, indicating the extract's safety. Antiplasmodial activity was evaluated using both suppressive and curative models in Plasmodium berghei-infected albino mice. The extract at 1000 mg/kg significantly suppressed parasitemia by 58.8% in the early infection (suppressive test) and reduced parasitemia by 61.8% in the established infection (curative test). Chloroquine, the standard drug at 5 mg/kg, produced higher parasite suppression (84.52%) and curative effects (84.50%) compared to the extract. The results suggest that the methanol extract of S. multiflorus aerial parts possesses antiplasmodial activity, supporting its traditional use in malaria management.
- 9 January 2025
- Published by Etflin in Sciences of Phytochemistry
- Vol. 4 (1) , 55-61
Open AccessPhytochemical and Antiplasmodial Studies of Methanol Extract from Aerial Parts of Scadoxus multiflorus
Scadoxus multiflorus, a fleshy herbaceous plant with a large bulb, has been traditionally used in ethnomedicine for treatment of malaria, ulcers, cardiotonic activity and stimulant in debility. This study aimed to conduct phytochemical screening and evaluate the antiplasmodial activity of its aerial parts. The plant material was extracted with methanol using maceration process, and the crude extract was partitioned into hexane, chloroform, ethyl acetate, and butanol fractions. Qualitative phytochemical screening revealed the presence of tannins, flavonoids, alkaloids, terpenoids, steroids, saponins, phenols, and cardiac glycosides in the crude extract and fractions. Quantitative analysis revealed that phenolic compounds were the most abundant in the crude extract (198.32 mg/g), while alkaloids were the least (51.14 mg/g). The n-hexane fraction, however, had the highest tannin content (215 mg/g). Acute toxicity testing, following OECD 2008 guidelines, showed that the median lethal dose (LD₅₀) was greater than 5000 mg/kg, indicating the extract's safety. Antiplasmodial activity was evaluated using both suppressive and curative models in Plasmodium berghei-infected albino mice. The extract at 1000 mg/kg significantly suppressed parasitemia by 58.8% in the early infection (suppressive test) and reduced parasitemia by 61.8% in the established infection (curative test). Chloroquine, the standard drug at 5 mg/kg, produced higher parasite suppression (84.52%) and curative effects (84.50%) compared to the extract. The results suggest that the methanol extract of S. multiflorus aerial parts possesses antiplasmodial activity, supporting its traditional use in malaria management.
- Open Access
- 30 September 2024
- Published by Science Publishing Group in Journal of Drug Design and Medicinal Chemistry
- Vol. 10 (3) , 67-80
In-Silico Screening of Prenylated Quercetin from Globimetula oreophila Against Plasmodium falciparum Enzymes: Hope for New Antimalarial Drugs
Malaria continues to be one of the most devastating global health problems due to the high morbidity and mortality it causes in endemic regions. The search for new antimalarial targets is vital because of the increasing prevalence of drug resistance in malaria parasites. Malarial proteases constitute promising therapeutic targets as they play important roles in the parasite life cycle. The inhibition of these enzymes has pharmacological and therapeutic significance since they are involved in numerous processes, including the development, invasion, egress, and breakdown of host hemoglobin to release amino acids for parasite sustenance. In this study, in silico techniques were used to shed light on the mechanisms underlying the inhibitory effects of prenylated quercetin isolated from Globimetula oreophila on plasmepsin I and II, falciparum 2 and 3, Plasmodium falciparum calcium-dependent protein kinase 2, dihydrofolate reductase-thymidylate synthase, and serine repeat antigen 5. The test compound significantly interacts with key enzyme binding pockets through hydrogen bonds, van der Waals, and hydrophobic interactions, influencing protease specificity control. Crucial ligand features like carbonyl and hydroxyl groups were identified as essential for receptor interactions. Comparative analysis revealed the test compound's strong binding affinities with energies ranging from -6.4 Kcal/mol to -9.4 Kcal/mol, indicating competitive potential against various enzymes, particularly excelling against Pf DHFR-TS, plasmepsin-I, and SERA5 compared to native ligands. This suggests the compound's ability to competitively inhibit enzyme activity by targeting co-factor binding sites, especially with specific proteases, holding promise for therapeutic applications as potent inhibitors for the prevention and treatment of malaria.
- 30 September 2024
- Published by Science Publishing Group in Journal of Drug Design and Medicinal Chemistry
- Vol. 10 (3) , 67-80
Open AccessIn-Silico Screening of Prenylated Quercetin from Globimetula oreophila Against Plasmodium falciparum Enzymes: Hope for New Antimalarial Drugs
Malaria continues to be one of the most devastating global health problems due to the high morbidity and mortality it causes in endemic regions. The search for new antimalarial targets is vital because of the increasing prevalence of drug resistance in malaria parasites. Malarial proteases constitute promising therapeutic targets as they play important roles in the parasite life cycle. The inhibition of these enzymes has pharmacological and therapeutic significance since they are involved in numerous processes, including the development, invasion, egress, and breakdown of host hemoglobin to release amino acids for parasite sustenance. In this study, in silico techniques were used to shed light on the mechanisms underlying the inhibitory effects of prenylated quercetin isolated from Globimetula oreophila on plasmepsin I and II, falciparum 2 and 3, Plasmodium falciparum calcium-dependent protein kinase 2, dihydrofolate reductase-thymidylate synthase, and serine repeat antigen 5. The test compound significantly interacts with key enzyme binding pockets through hydrogen bonds, van der Waals, and hydrophobic interactions, influencing protease specificity control. Crucial ligand features like carbonyl and hydroxyl groups were identified as essential for receptor interactions. Comparative analysis revealed the test compound's strong binding affinities with energies ranging from -6.4 Kcal/mol to -9.4 Kcal/mol, indicating competitive potential against various enzymes, particularly excelling against Pf DHFR-TS, plasmepsin-I, and SERA5 compared to native ligands. This suggests the compound's ability to competitively inhibit enzyme activity by targeting co-factor binding sites, especially with specific proteases, holding promise for therapeutic applications as potent inhibitors for the prevention and treatment of malaria.